- CA$29.32m
- CA$29.09m
- CA$1.91m
Annual income statement for Cheelcare, fiscal year end - April 30th, CAD millions except per share, conversion factor applied.
2022 February 28th | 2023 February 28th | 2024 February 29th | 2025 February 28th | 2026 April 30th | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | PROSPECTUS | ARS | ARS | ARS | ARS |
| Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
| Status: | Final | Final | Final | Final | Final |
| Revenue | |||||
| Total Revenue | 0 | 0 | 0 | 0 | 1.91 |
| Cost of Revenue | |||||
| Gross Profit | — | — | — | — | 0.465 |
| Selling / General / Administrative Expenses | |||||
| Research And Development | |||||
| Depreciation and Amortization | |||||
| Operating Interest Expense / Income | |||||
| Unusual Expense / Income | |||||
| Total Operating Expenses | 0.008 | 0.12 | 0.044 | 0.066 | 6.31 |
| Operating Profit | -0.008 | -0.12 | -0.044 | -0.066 | -4.41 |
| Total Net Non Operating Interest Income / Expense | |||||
| Other Net Non Operating Costs | |||||
| Net Income Before Taxes | -0.008 | -0.12 | -0.044 | -0.066 | -4.86 |
| Net Income After Taxes | -0.008 | -0.12 | -0.044 | -0.066 | -4.86 |
| Net Income Before Extraordinary Items | |||||
| Net Income | -0.008 | -0.12 | -0.044 | -0.066 | -4.86 |
| Income Available to Common Shareholders Excluding Extraordinary Items | |||||
| Income Available to Common Shareholders Including Extraordinary Items | |||||
| Diluted Net Income | -0.008 | -0.12 | -0.044 | -0.066 | -4.86 |
| Diluted Weighted Average Shares | |||||
| Basic EPS Including Extraordinary Items | |||||
| Diluted EPS Including Extraordinary Items | |||||
| Diluted EPS Excluding Extraordinary Items | |||||
| Normalised Income Before Taxes | |||||
| Normalised Income After Taxes | |||||
| Normalised Income Available to Common Shareholders | |||||
| Diluted Normalised EPS | -0.005 | -0.08 | -0.029 | -0.044 | -0.178 |